US 11,702,449 B2
Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient
Young Myeong Kim, Gangwon-do (KR); Yi Yong Baek, Gyeonggi-do (KR); Won Jin Park, Gyeonggi-do (KR); Jeong Hun Kim, Seoul (KR); and Dong Hyun Jo, Seoul (KR)
Assigned to AVIXGEN INC., Seoul (KR)
Filed by AVIXGEN INC., Seoul (KR)
Filed on May 17, 2021, as Appl. No. 17/322,291.
Application 17/322,291 is a continuation of application No. 15/777,541, granted, now 11,040,999, previously published as PCT/KR2016/007246, filed on Jul. 5, 2016.
Claims priority of application No. 10-2015-0175853 (KR), filed on Dec. 10, 2015.
Prior Publication US 2021/0292363 A1, Sep. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 5/11 (2006.01); A61K 38/07 (2006.01); A61P 27/02 (2006.01); A61P 35/00 (2006.01); A61K 38/00 (2006.01)
CPC C07K 5/1019 (2013.01) [A61P 27/02 (2018.01); A61P 35/00 (2018.01); A61K 38/00 (2013.01)] 6 Claims
OG exemplary drawing
 
1. A pharmaceutical composition for treating psoriasis comprising:
a peptide consisting of Arg-Leu-Tyr-Glu (SEQ. ID NO: 1), in which N-terminal L-Arg is acetylated; and
a pharmaceutically acceptable carrier.